文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

ICU保护性通气台架模型中不同吸入镇静装置对机械功率的影响

Effects on mechanical power of different devices used for inhaled sedation in a bench model of protective ventilation in ICU.
PubMed 文献 · Ann Intensive Care · 2024-01-29
一句话结论在保护性通气台架模型中,三种吸入镇静装置均使机械功率增加超过50%,可能限制其在ARDS中的获益。

本研究为台架研究,比较三种ICU可用的吸入七氟烷装置(AnaConDa-50 mL、AnaConDa-100 mL、MIRUS)对机械功率(MP)的影响。使用测试肺模型设置三种顺应性(20、40、60 mL/cmH2O),模拟低潮气量保护性通气,PEEP为5和15 cmH2O,在环境温度和干燥条件下进行。插入装置后,以15%步长增加呼吸频率或潮气量直至EtCO2恢复基线,用简化方程计算MP。结果显示,MIRUS(+78±13%)和ANA-100(+100±11%)的EtCO2升高显著大于ANA-50(+49±7%);调整分钟通气量使EtCO2正常化后,所有装置MP均增加超过50%,ANA-50增加最少(p<0.05 vs ANA-100和MIRUS);Costa指数在所有实验条件下增加超过20%。在体温、环境压力和气体水饱和条件下重复实验证实主要结果。

要点

  • 三种吸入镇静装置均使机械功率增加超过50%,ANA-50增加最少(p<0.05 vs ANA-100和MIRUS)。
  • MIRUS和ANA-100的EtCO2升高幅度(+78±13%和+100±11%)显著大于ANA-50(+49±7%)。
  • Costa指数在所有实验条件下增加超过20%。
  • 在体温、环境压力和气体水饱和条件下重复实验,证实EtCO2正常化后所有装置MP增加超过50%。

适用人群与场景

  • 接受有创机械通气的ARDS患者,使用吸入镇静时需考虑对机械功率的影响。
  • 台架模型模拟低潮气量保护性通气,设置三种顺应性(20、40、60 mL/cmH2O),PEEP为5和15 cmH2O,环境温度和干燥条件。

处置流程与药物剂量

  • 插入吸入镇静装置后,以15%步长增加呼吸频率或潮气量直至EtCO2恢复基线值。
  • 使用简化方程计算机械功率(MP),在基线和EtCO2校正后分别计算。

研究设计与关键结果

  • 台架研究比较三种吸入七氟烷装置(AnaConDa-50 mL、AnaConDa-100 mL、MIRUS)对机械功率的影响。
  • 插入装置后EtCO2升高:MIRUS +78±13%,ANA-100 +100±11%,ANA-50 +49±7%,MIRUS和ANA-100显著大于ANA-50。
  • 调整分钟通气量使EtCO2正常化后,所有装置MP增加超过50%,ANA-50增加最少(p<0.05 vs ANA-100和MIRUS)。
  • Costa指数(驱动压×4+呼吸频率)在所有实验条件下增加超过20%。
  • 在体温、环境压力和气体水饱和条件下重复实验,证实EtCO2正常化后所有装置MP增加超过50%。

证据类型、等级与局限

  • 证据类型:台架研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,吸入镇静装置在保护性通气台架模型中显著增加机械功率,可能限制其在ARDS中的获益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Inhaled sedation during invasive mechanical ventilation in patients with acute respiratory distress syndrome (ARDS) has received increasing attention. However, inhaled sedation devices increase dead-space ventilation and an undesirable effect is the increase in minute ventilation needed to maintain CO2 removal. A consequence of raising minute ventilation is an increase in mechanical power (MP) that can promote lung injury. However, the effect of inhaled sedation devices on MP remains unknown.

METHODS: We conducted a bench study to assess and compare the effects of three devices delivering inhaled sevoflurane currently available in ICU (AnaConDa-50 mL (ANA-50), AnaConDa-100 mL (ANA-100), and MIRUS) on MP by using a test lung model set with three compliances (20, 40, and 60 mL/cmH2O). We simulated lung-protective ventilation using a low tidal volume and two levels of positive end-expiratory pressure (5 and 15 cmH2O) under ambient temperature and dry conditions. Following the insertion of the devices, either the respiratory rate or tidal volume was increased in 15%-steps until end-tidal CO2 (EtCO2) returned to the baseline value. MP was calculated at baseline and after EtCO2 correction using a simplified equation.

RESULTS: Following device insertion, the EtCO2 increase was significantly greater with MIRUS (+ 78 ± 13%) and ANA-100 (+ 100 ± 11%) than with ANA-50 (+ 49 ± 7%). After normalizing EtCO2 by adjusting minute ventilation, MP significantly increased by more than 50% with all inhaled sedation devices compared to controls. The lowest increase in MP was observed with ANA-50 (p < 0.05 versus ANA-100 and MIRUS). The Costa index, another parameter assessing the mechanical energy delivered to the lungs, calculated as driving pressure × 4 + respiratory rate, significantly increased by more than 20% in all experimental conditions. Additional experiments performed under body temperature, ambient pressure, and gas saturated with water vapor conditions, confirmed the main results with an increase in MP > 50% with all devices after normalizing EtCO2 by adjusting minute ventilation.

CONCLUSION: Inhaled sedation devices substantially increased MP in this bench model of protective ventilation, which might limit their benefits in ARDS.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Pellet PL, Stevic N, Degivry F, et al. Effects on mechanical power of different devices used for inhaled sedation in a bench model of protective ventilation in ICU. Ann Intensive Care. 2024. PMID: 38285231. doi:10.1186/s13613-024-01245-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。